SSIはCRC(治験コーディネーター)による質の高い治験支援を提供するSMOのリーディングカンパニーです。

WHO
WE ARE

As a CMIC GROUP company

As a CMIC GROUP company

CMIC Group is engaged in innovation-driven business that supports drug development.
As a member of the Group, SSI conducts business from the perspective of future medicine.

SSI is part of CMIC Group that established the first Contract Research Organization (CRO) in Japan. Based on a unique ‘Pharmaceutical Value Creator’ (PVC) business model, CMIC Group business extends broadly from its core CRO business to services associated with drug development, manufacturing, and marketing, in addition to in-house development of orphan drugs and diagnostics. This comprehensive capability serves as the backbone of SSI, and we actively collaborate with other affiliates to advance medical innovation in Japan.

As a CMIC Group company

Based on CMIC Group’s fundamental principle of “Providing patients with better medicine faster”, SSI aims to be a company that contributes to the establishment of ‘Evidence-Based Medicine’ (EBM)

CMIC HOLDINGS Co., Ltd.

As a CMIC Group company

CMIC Group Services

CMIC Group will try to be an effective partner by providing PVC business solutions that encompass the entire value-chain of pharmaceutical development, including R&D, manufacturing, marketing and sales. It also continues to expand its service offering both domestically and internationally.

PVC Pharmaceutical Value Creator CMIC Group Services

CMIC Group provides comprehensive support for the value chain of pharmaceutical companies.

CMIC Group provides comprehensive support for the value chain of pharmaceutical companies.

Read More